Blog

Latest advancements in FLASH radiotherapy from ESTRO24

Photo taken from ESTRO/LinkedIn

Aug 17, 2024, 12:32

Latest advancements in FLASH radiotherapy from ESTRO24

European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn:

“Latest advancements in FLASH radiotherapy from ESTRO24: From pioneering research insights to multidisciplinary innovations, explore how this cutting-edge technology is reshaping cancer treatment.”

Source: ESTRO/LinkedIn

Find more posts about ESTRO24 on OncoDaily.

cancer Cancer research cancer treatment ESTRO24 European SocieTy for Radiotherapy and Oncology FLASH radiotherapy OncoDaily Oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Jan 20, 2025, 04:32

Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma

Blog

Jan 20, 2025, 04:29

Katsuaki Maehara: Lung EGFR mutations catalog

Opinion

Jan 20, 2025, 04:25

Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities

Blog

Jan 20, 2025, 04:21

Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family

Insight

Jan 20, 2025, 04:14

Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra

Insight

Jan 20, 2025, 04:00

FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer

Career

Jan 20, 2025, 03:10

Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research

Blog

Jan 20, 2025, 02:54

Drew Moghanaki: A new medical oncology position at the VA Medical Center in Long Beach

Science

Jan 20, 2025, 02:44

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL

Science

Jan 20, 2025, 02:16

Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer

Blog

Jan 20, 2025, 02:14

Akriti Jain: Grateful to present at Cleveland Clinic ASH review

Career

Jan 19, 2025, 23:12

Kimryn Rathmell Steps Down as NCI Director, Concluding a Pivotal Leadership Era